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Age-related macular degeneration (AMD) is a progressive retinal degeneration resulting
in central visual field loss, ultimately causing debilitating blindness. AMD affects
18% of Americans from 65 to 74, 30% older than 74 years of age and is the
leading cause of severe vision loss and blindness in Western populations. While
many genetic and environmental risk factors are known for AMD, we currently
know less about the mechanisms mediating disease progression. The pathways
and mechanisms through which genetic and non-genetic risk factors modulate
development of AMD pathogenesis remain largely unexplored. Moreover, current
treatment for AMD is palliative and limited to wet/exudative forms. Retina is a complex,
heterocellular tissue and most retinal cell classes are impacted or altered in AMD.
Defining disease and stage-specific cytoarchitectural and metabolic responses in
AMD is critical for highlighting targets for intervention. The goal of this article is
to illustrate cell types impacted in AMD and demonstrate the implications of those
changes, likely beginning in the retinal pigment epithelium (RPE), for remodeling
of the the neural retina. Tracking heterocellular responses in disease progression
is best achieved with computational molecular phenotyping (CMP), a tool that
enables acquisition of a small molecule fingerprint for every cell in the retina. CMP
uncovered critical cellular and molecular pathologies (remodeling and reprogramming)
in progressive retinal degenerations such as retinitis pigmentosa (RP). We now
applied these approaches to normal human and AMD tissues mapping progression
of cellular and molecular changes in AMD retinas, including late-stage forms of the
disease.
Keywords: age-related macular degeneration (AMD), retinal pigment epithelium (RPE), computational molecular
phenotyping (CMP), retina, photoreceptor, Müller cell, retinal remodeling, neural remodeling
Abbreviations: AMD, age-related macular degeneration; RP, retinitis pigmentosa; RPE, retinal pigment epithelium;
D, aspartate; R, arginine; E, glutamate; G, glycine; J, glutathione; Q, glutamine; τ, taurine; 1D4, rod opsin; rg-opsin,
cone opsin; GS, glutamine synthetase; GABA, γ-aminobutyric acid; CRALBP, Retinaldehyde binding protein 1; IgG,
immunoglobulin G; EM, electron microscopy; rgb, red green blue; ONL, outer nuclear layer; ISODATA, Iterative
Self-Organizing Data Analysis Technique; CMP, Computational Molecular Phenotyping; µM, micrometer.
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INTRODUCTION
Given that age-relatedmacular degeneration (AMD) is effectively
a deafferentation of the neural retina caused by the death of
photoreceptors, our goal with this study was to explore whether
or not AMD retinas exhibited the same retinal plasticity and
remodeling observed in retinitis pigmentosa (RP; Li et al., 1995;
de Raad et al., 1996; Fletcher and Kalloniatis, 1996; Fariss et al.,
2000; Machida et al., 2000; Strettoi and Pignatelli, 2000; Strettoi
et al., 2002, 2003; Jones et al., 2003, 2005, 2006, 2011, 2012;
Marc and Jones, 2003; Marc et al., 2003, 2005, 2007, 2008;
Cuenca et al., 2004; Jones and Marc, 2005; Pu et al., 2006;
Aleman et al., 2007). AMD, like RP is a collection of defects.
In AMD, these defects arise from from identified defects in
CFH (Boon et al., 2009), ARMS2 (Fritsche et al., 2008; Friedrich
et al., 2011), HTRA1 (Dewan et al., 2006), oxidative stress
(Kunchithapautham et al., 2014) and inflammation (Ozaki et al.,
2014) that ultimately result in pathologies manifesting from
the molecular levels to tissue levels. Ultimately however, in
both dry and wet forms of AMD, photoreceptors die which
we hypothesized initiates the same cascade of neural cell death
and plasticity observed in other retinal degenerative diseases
such as RP.
For this study, we applied a set of technologies that
reveal a metabolic ‘‘fingerprint’’ for cells while preserving
all anatomical relationships. These approaches, computational
molecular phenotyping (CMP) parse tissues into metabolic
space, revealing structure in addition to metabolism. This
study revealed fundamental and previously unknown findings
including alterations in metabolic stability of retinal pigment
epithelium (RPE) cells, particularly those above regions of
pathology. We show evidence of photoreceptor cell stress that
occurs prior to cell death and indications that cone opsin
processing may be differentially compromised vs. rod opsin
processing, specifically in AMD as compared with other retinal
degenerative diseases. Being able to visualize metabolism is a
powerful feature of this study as we’ve documented metabolic
alterations in Müller cells which is a novel finding for AMD,
even though it has been described for other retinal degenerative
diseases. However, themost significant finding of this study is the
extensive description of negative retinal plasticity, termed retinal
remodeling that involves inner retinal neurons projecting to
aberrant locations. This remodeling occurs underneath obvious
regions of pathology like underneath drusen, but also in regions
where cone and rod photoreceptors are still present suggesting




Human AMD tissue was obtained within 6 h post mortem from
The Foundation Fighting Blindness Retina Donor Program, at
the University of Utah Lions Eye Bank. Institutional approval
for use of human eyes was obtained from the University of
Utah and followed the tenets of the Declaration of Helsinki.
All retinal tissues and data were de-identified in accordance
with HIPPA Privacy Rules. Retinas from patients with a
diagnosis of AMD were identified from both medical records
and by post-mortem examination of globes, retinas were
photographed and gross pathological features were documented.
Five millimeter wide strips were dissected out starting at
the optic nerve head and traversing horizontally through the
macula and out to the temporal ora serrata. Portions of the
strips collected for histological purposes exhibiting regions
of pathology (drusen, hypopigmentation, neovascular growth)
were trephine punched, prepared and processed for both
light and electron microscopic analyses. For CMP, eyes are
immersion-fixed overnight in buffered 2.5% glutaraldehyde/1%
formaldehyde and resin embedded and serially sectioned at
70–250 nm (Marc et al., 1995). Parafoveal and mid-peripheral
retina was utilized for the CMP in this study because many
small molecule metabolic signals in the post-mortem fovea
degrade more rapidly than peripheral retina for unknown
reasons that may relate to increased metabolic demands (Napper
and Kalloniatis, 1999). Retinas were obtained from three normal,
control human subjects and eight AMD subjects. Six of the AMD
subjects had diagnoses of dry AMD and two had diagnoses of wet
AMD, one early in the course of the disease and one late in the
progression of the disease.
Non-Human Primate Tissue
Eyes from adult male and female olive baboons (Papio anubis)
were obtained during necropsy from the Southwest Foundation
for Biomedical Research (San Antonio, TX, USA). Anesthesia
and euthanasia conform to institutional animal care and use
authorizations and the ARVO Statement for the Use of Animals
in Ophthalmic and Visual Research.
OCT
Enucleated globes with the anterior segment removed were
submerged post-fixation in a large scintillation chamber filled
with normal saline for high resolution mapping and correlation
with histological/CMP analysis. High resolution scans were
performed with a Heidelberg Spectralis, OCT.
Immunocytochemistry
Retinal neurons were classified by CMP (Marc and Jones, 2002).
To generate signals for CMP, tissues were probed with IgGs
selective for individual small or macro molecules [aspartate
(D), arginine (R), glutamate (E), glycine (G), glutathione (J),
glutamine (Q), taurine (τ), γ-aminobutyric acid (GABA; γ),
CRALBP, rod opsin (1D4), cone opsin (rg-opsin) or glutamine
synthetase (GS; Table 1], visualized with secondary antibodies
conjugated to 1.4 nm gold, followed by silver intensification
(Marc et al., 1995; see Table 1). Primary antibody incubations
was performed overnight at room temperature and visualized
with goat anti-rabbit secondary IgG coated with 1.4 nm gold
(Nanoprobes Nanogoldr -anti Rabbit IgG) and silver intensified
for CMP (Marc et al., 1995). All probed signals derive from
200 nm thick sections and all epitope binding of antibodies
occurs in the first 5 nm from the surface of the section, making
all signals quantitative (Kalloniatis and Fletcher, 1993;Marc et al.,
1995).
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TABLE 1 | List of antibodies.
Reagent SKU RRID Source Dilution
anti-L-aspartate IgG D100R AB_2341093 Signature immunologics 1:100
anti-L-glutamate IgG E100R AB_2532055 Signature immunologics 1:100
anti-glycine IgG G100R AB_2532057 Signature immunologics 1:100
anti-glutathione IgG J100R AB_2532058 Signature immunologics 1:100
anti-L-glutamine IgG Q100R AB_2532059 Signature immunologics 1:100
anti-taurine IgG TT100R AB_2532060 Signature immunologics 1:100
anti-GABA IgG YY100R AB_2532061 Signature immunologics 1:100
anti-GS IgG 610517 AB_397879 BD Biosciences 1:50
anti-CRALBP IgG NA AB_2314227 Gift of Dr. Jack Saari 1:400
anti-rod opsin 1D4 IgG NA AB_2315015 Gift of Dr. Robert Molday 1:4000
anti-cone opsin IgG AB5405 AB_177456 EMD Millipore 1:1000
Computational Molecular Phenotyping
(CMP)
Images were captured as 8-bit high-resolution (243 nm/pixel)
images (Marc and Jones, 2002), mosaicked, and registered with
ir-tweak https://www.sci.utah.edu/download/ncrtoolset.html
into large image databases. Cell classification was performed
on N-dimensional (N-space) monochrome images via k-means
or Iterative self-organizing data analysis technique (ISODATA)
clustering (Marc et al., 1995; Marc and Cameron, 2001; Marc
and Jones, 2002) using PCI Geomatica (PCI Geomatics,
Inc.) for pixel based clustering and mask generation into
theme maps. Detailed theme map generation first involves
production of raw classification theme maps (Marc et al.,
1995; Kalloniatis et al., 1996), which is the mathematical
division of regions into statistically separable classes based
on multiple channel inputs. Adobe Photoshop (Adobe,
San Jose, CA, USA) was used for final image generation.
For display only, raw data channels are linearly contrast-
stretched over a 30–220 pixel value range and sharpened
with unsharp masking. Molecular signals were visualized
as selected rgb maps encoding three molecular signals as
red, green, and blue, respectively, e.g., γ.G.E → rgb which
assigns GABA, glycine and L-glutamate to red, green, and blue
color channels, respectively. Monochrome images are density
mapped and rgb images intensity mapped (Marc et al., 1995).
Both high and low magnification electron microscopy (EM)
images montages are captured digitally as 12-bit monochrome
channels and assembled into large mosaics (Anderson et al.,
2009).
Electron Microscopy (EM)
Tissues were postfixed in 1% buffered osmium tetroxide,
followed by resin embedding. Large scale transmission electron
microscopy (TEM) was then performed, creating EM mosaics
as previously described (Anderson et al., 2009) on 90-nm lead-
stained sections on single-slot grids.
RESULTS
We display aged and AMD tissues with both individual gray
scale and rgb mapping reflecting small molecule concentrations.
Mapping of signals as γ.G.E→ rgb triplets allows visualization
of large swaths of tissue for rapid review, such as GABA (γ)
and glycine (G) amacrine cells, photoreceptors, bipolar cells,
and ganglion cells, whereas the mapping of τ.Q.E → rgb sets
apart Müller cells, the retinal pigmented epithelium, and other
elements from all other cells. Human retina shows essentially
the same composite patterns of small-molecule signatures as
those in the primate, cat, rabbit and rat retinas (Fletcher
and Kalloniatis, 1996; Kalloniatis et al., 1996; Marc et al.,
1998b; Marc, 1999c). Classifying all the data with k-means
or ISODATA clustering produces raw theme maps, which are
then converted to refined theme maps superimposed on a
single reference channel. Theme maps and rgb displays simplify
tracking of 10 major cell phenotypes; photoreceptors, horizontal
cells, ON-center cone bipolar cells identified as glycine (G)
bipolar cells (Kalloniatis et al., 1996), all remaining bipolar cells
as a mixed group of rod and OFF-center cone bipolar cells,
glycine (G) amacrine cells, GABA (γ) amacrine cells, ganglion
cells, Müller cells, vascular elements, and the retinal pigmented
epithelium. These 10 phenotypes account for effectively all retinal
space.
Human tissues were harvested within 3–5 h post mortem
for analysis. Small molecules are robust signals that can
be used for discrimination of individual cell classes (Marc
and Liu, 1985; Marc et al., 1990, 1995; Kalloniatis et al.,
1996; Marc, 1999a,b; Marc and Cameron, 2001; Marc and
Jones, 2002) but some signals are impacted by ischemia.
Redistributions in small molecules due to neuronal reverse
transport and glial accumulation are detectable within
minutes of ischemia in retina, causing clear banding in
the IPL and increases of GABA in the Müller cells. GABA
signals in the peripheral retina are better preserved than in
central retina. With increasing time, barring re-perfusion,
GABA builds up in Müller cells, while other small molecule
signals remain intact. While it is difficult to obtain human
tissues within a window where GABA signals do not
show alterations, this does not interfere with cellular class
identification.
Aside from these alterations in GABA, aged human retinas
show normal retinal stratification and organization. However,
many aged normal retinas (e.g., Figure 1), with no previous
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FIGURE 1 | Normal aged, peripheral human retina. (A) γ.G.E→ rgb
mapping of human peripheral retina from a 78 year old male with no diagnosis
of AMD. Normal topology and stratification of the retina is observed, but the
earliest indications of potential pathology are present in the bricking of the
retinal pigment epithelium (RPE), a common finding in aged, human retina.
Also, note the existence of a small druse, labeled with asterisk. (B) τ.Q.E→
rgb mapping revealing Müller glial populations in yellow. Scale bar = 40 µM.
diagnosis of AMD exhibit pathologies in the RPE that are
suggestive of changes due to aging or even incipient AMD
(pre-diagnosis) with the identification of occasional small, hard
druse, (asterisk in Figure 1) though isolated druse are not
thought to be associated with age related maculopathy (Sarks
et al., 1999).
RPE
Metabolic signatures in individual RPE cells of normal tissues
are indistinguishable from each other. This has been true
in our analysis of over 1000 retinal samples from at least
70 vertebrate species, but patches of RPE with variable
signals are common in AMD retinas. We term this pattern
‘‘bricking, ’’ similar to a running bond course with two colors
of bricks. In normal RPE cells, levels of amino acids are
consistent and uniform. In AMD samples, levels of taurine,
glutamate, and glutathione in the RPE demonstrate wide
variability across immediate neighbors, notably in the macula.
However, occasional tiling of the RPE is not uncommon in
aged human samples (Figure 1), and could be indicative of
normal aging. But it also may be an early manifestation of
AMD or an explicit risk phenotype for AMD. Regardless,
extensive bricking of RPE cells correlates with the presence
of other pathologies associated with AMD. More advanced
cases of AMD show dramatic alterations, particularly where
RPE cells are near drusen deposits. Critically, the neural
retina directly under deposits is remodeled and a cascade of
pathology spanning photoreceptors, Müller cells and eventually,
neurons in the retina are all metabolically and/or structurally
compromised.
RPE expresses uniform, moderate levels of glutathione, a
redox control molecule. In most species the concentration
ranges from 1 to 5 mM, with all RPE cells in a sample
showing the same level. Glutathione levels also tend to decrease
in concentration with eccentricity in normal retinas, but
exhibits marked increases in the central retina of patients with
diagnoses of AMD. Additionally, RPE glutathione levels are
heterogeneous in AMD retinas, as are other small molecules
expressed in the RPE, including glutamate and taurine.
(Figure 2). Individual RPE cells from AMD patients often
demonstrate paradoxically dramatically lower or higher levels
of both glutathione and taurine in unpredictable patterns,
in addition to a dramatic loss of other central metabolic
carbon skeleton amino acids such as core metabolites such
as glutamate, which may be a signature of incipient cell
death.
FIGURE 2 | Human parafoveal retina from a 76 year old patient with advanced AMD showing taurine labeling in the RPE internal to the vascular
choroid (Ch). Normal levels of taurine in the RPE are typically high and uniform. As RPE cells experience cell stress, they adopt a “bricked” or non-uniform
appearance suggesting that they are becoming uncoupled. While this pathology is present to a limited degree in ostensibly normal aged human retina, it becomes
much more dramatic in regions of obvious AMD related pathology. The white spots in the RPE likely indicate regions of lipid accumulation and could represent
lipofuscin/melanolipofuscin granules. Also of note, are the accumulations of intensely taurine positive deposits underneath the RPE and above the photoreceptor
outer segments (arrows). These deposits are not apical processes of the RPE as they have much higher concentrations of taurine than do the RPE cells.
Scale bar = 40 µM.
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FIGURE 3 | Peripheral retina from a 71 year old AMD patient
demonstrating small and mid-size drusen (arrows), and RPE bricking
particularly underneath large druse. (A) γ.G.E→ rgb. (B) Post-mortem
ex-vivo OCT data demonstrating correlates with histology in (A,C,D) with inset
demonstrating higher magnification views of RPE histology shown in
rectangle. (C) Taurine labeling demonstrating RPE bricking. (D) Glutamate
labeling demonstrating RPE bricking and altered cone photoreceptors (boxes)
revealing cones with low glutamate concentrations. Scale bar = 80 µM.
Even under small drusen, RPE cells are ‘‘bricked’’. Figure 3
shows an area of retina that is largely preserved from a 71
year old patient with advanced AMD. However, all of the RPE
cells around these drusen (arrows) are clearly compromised
with extensively altered metabolism shown in the rectangles
and inset of Figure 3B. We also include post-mortem ex-
vivo OCT data, co-registered to the histology in Figure 3B to
demonstrate features such as the small 20–60 µM drusen seen
in histology are difficult to assess in post mortem OCT and
that the other changes being shown indicative of pathologies in
retinas might be invisible to current commonly available clinical
assessments.
The variability of labeling in RPE cells is not due to any
alterations in pigment composition of the RPE across AMD
samples, nor between regions of retina within samples seen in
Figure 4. Regional variation in pigment has never been described
on an RPE cell to cell basis and could not explain the variations
in signatures observed in AMD samples, where variations in
labeling in small molecule signals of glutamate, glutamine,
(Figures 1, 3, 5) and taurine (Figures 2, 4, 5, 8, 9) within the
RPE in unpredictable patterns is commonly seen. This is the case
particularly underneath photoreceptors that appear with altered
metabolism or other pathological findings in and around the
photoreceptors such as the taurine positive deposits described in
Figures 2, 4.
Photoreceptors
In addition to indications of cell stress in the RPE, retinas from
patients with AMD demonstrate photoreceptor abnormalities.
In some regions, rod photoreceptors demonstrate rhodopsin
delocalization (Milam et al., 2002) underneath small ∼10 µm
diameter deformations that may represent subretinal drusenoid
deposits (SDD) or aberrant apical processes of RPE cells
that displace the outer segments of the rod photoreceptors
(Figure 5A). Cone opsin, is clearly delocalized around the
inner segments and cell bodies in regions where the RPE is
bricked and builds up large deposits underneath those RPE cells
filled with taurine and glutamate and ringed by cone opsins
suggestive of RPE defects in both retinoid processing (Baehr
et al., 2003) and perhaps cone-selective phagocytosis. Cone
opsins also undergo cone opsin delocalization to a greater degree
in the macula than in the mid periphery and exhibit altered
glutamate signatures underneath druse suggesting challenged
metabolism or cell stress, indicating that retinoid processing
is compromised (Figures 3, 6). Figure 3D demonstrates cone
photoreceptors with altered glutamate metabolism. These cone
photoreceptors have far lower glutamate concentrations in them
than the surrounding cone photoreceptors. At late stages of AMD
in both dry and wet forms, rhodopsin is still present, yet cone
opsins completely disappear. Since each cone photoreceptor is
ensheathed by a single RPE cell (Gao and Hollyfield, 1992),
defects in the RPE may be rapidly expressed in cones.
Another common, but structurally unusual finding is a
buildup of taurine underneath the RPE in (Figures 2, 6)
enveloped by a thin ring of membrane containing cone opsin.
These deposits are a mix of taurine at very high concentrations,
glutamate, aspartate, glutamine at lower concentrations and also
appear to have lipid droplets associated with them. This may
represent specific failure to cycle cone outer segments.
Also commonly observed are isolated cone photoreceptors
with dramatically lower levels of both taurine in RPE above cone
photoreceptors that exhibit low levels glutamate suggesting the
possibility of a late phase cell death signature. Additionally, cone
inner segment glutathione profiles in normal retina demonstrate
very little heterogeneity with very low concentrations that
decrease to effectively zero in the peripheral retina. However
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FIGURE 4 | (A) RPE from a 75 year old male with no history of AMD. (B) A 76 year old male with AMD and (C) mature male Papio anubis. The RPE is shown in each
column labeled for taurine (τ), glutamine (Q), glutathione (J), GABA (γ), CRALBP and glutamate (E). This image most notably demonstrates the variability in taurine
content of the RPE cells compared with normal human and non-human primate but also demonstrates the lack of staining in GABA of the RPE indicating that any
pigment granules in the RPE do not alter or influence small molecule epitope detection. Also, note that CRALBP is upregulated over the normal human in AMD and
that a subset of the taurine deposits differentially contains glutamate as well. Scale bar = 80 µM.
in wet-AMD retinas, glutathione increases more than two-fold
in the fovea/macula over surrounding areas and demonstrates
heterogeneous concentrations. The increases in concentrations
return to more normal levels past 20 degrees eccentricity
(Figure 7). Cone inner segment taurine profiles show very high
concentrations of taurine in them with little variation across
all retinal eccentricities regardless of AMD status (data not
shown).
Müller Cells
Müller cells are one of the first cell classes in the retina to
show metabolic alterations in retinal degenerations (Jones et al.,
2003, 2005, 2006, 2011, 2012; Marc and Jones, 2003; Marc et al.,
2003, 1995; Jones and Marc, 2005). AMD retinas resemble RP
retinas in this regard. Glutamine and glutathione variability can
be observed in Müller cells of patients with early dry-AMD, with
spikes of more than double normal levels. This is also true in wet-
AMD (Figure 8).
Hypertrophy of glial cells occurs as photoreceptor cell bodies
in the outer nuclear layer (ONL) are lost (Figure 9). This may
be a result of Müller cell distal processes remaining after the
loss of photoreceptor cells in the ONL, or there may be actual
hypertrophy as in RP and RP related retinal degenerations.
As AMD progresses in both wet and dry forms , there is a
dramatic loss of GS labeling in Müller glia.
Inner Retinal Neurons
Early to mid-stage AMD is commonly associated with numerous
moderate to large drusen deposits in the sub-RPE space.
GABA, glycine and glutamate signals display morphological
changes in neurons directly under drusen (Figure 9A) while
taurine, glutamine, glutamate signals (Figure 9B) shows that
the Müller express metabolic variability in the same region.
Ectopic neurites of GABAergic amacrine cells and translocation
of glycinergic amacrine cells into the OPL and ONL and likely
into the IPL, particularly in regions around moderate to large
drusen formations, demonstrate that pathologic remodeling is
both local and unexpectedly fast in AMD, occurring even
while rod photoreceptors are present (Figures 9C,D). Neuronal
remodeling has been extensively characterized in RP and RP
models (Jones et al., 2003, 2005, 2006, 2011, 2012; Marc and
Jones, 2003; Marc et al., 2003, 2008; Jones and Marc, 2005).
DISCUSSION
AMD affects an estimated 18% of Americans from 65 to 74
and 30% older than 74 while the risk accumulates with age.
The single largest risk factor for AMD is age, but the pathways
and mechanisms through which genetic and non-genetic risk
factors modulate structural AMD pathogenesis remain largely
unexplored. Moreover, current treatment for AMD is palliative
and limited to exudative forms. While AMD represents one
of the best characterized diseases from a genetic perspective,
we currently know far less about the mechanisms mediating
disease progression, and other novel methods for interrogating
the anatomy and metabolism of retina are needed.
The goal of this work was to initiate an exploration of
the metabolic status and track fates of RPE and retinal cells
in retinas from patients with a diagnosis of AMD. There are
multiple presentations of RPE cells based upon morphological
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FIGURE 5 | (A) Parafoveal retina from a 71 year old male patient, 2 h 41 min
post mortem with a diagnosis of AMD labeled for rhodopsin demonstrating
extensive rod opsin delocalization in the rod photoreceptors down around the
inner segments and cell bodies. Asterisks denote small possible subretinal
drusenoid desposits (SDD) or aberrant apical processes of RPE deforming the
tips of the outer segments of photoreceptors. Notably, no rhodopsin buildup is
occurring underneath the RPE as occurs in many retinitis pigmentosa (RP)
diseases. (B) Demonstrating a slightly more oblique section of rhodopsin
labeling in a normal parafoveal non-human primate retina revealing no
rhodopsin delocalization. Scale bar = 8 µM.
analysis (Zanzottera et al., 2015) and the analysis presented
here demonstrates a number of metabolic intermediate states
that may reflect differential survival or stages of cell stress.
Serial monochrome images of normal human retina probed for
different small molecules display patterns of labeling similar to
those of other mammals. However, no comprehensive analysis
has yet been performed on aging retina to determine how these
cell populations change in senescence or AMD. The question
of aging is is beyond the scope of this manuscript, and we
refer the reader to some notable studies on the histology (Gao
and Hollyfield, 1992; Curcio et al., 1993; Samuel et al., 2011)
and molecular biology (Barron et al., 2001; Louie et al., 2002)
and genetics of ocular aging (Yoshida et al., 2002). Heterocellular
metabolism appears to be stable over time, even in aged retina
and across species (Marc et al., 1978, 1990, 1995, 1998b;Marc and
Lam, 1981; Marc and Liu, 1985; Marc, 1986, 1989, 1992, 1999c,
2004, 2008; Kalloniatis et al., 1994, 1996; Marc and Cameron,
2001; Marc and Jones, 2002).
Peri-foveal tissue: we acknowledge that AMD is thought
to be a macular disease, but are interested in the earliest
stages of AMD and it is reasonable to look to the edges
FIGURE 6 | Parafoveal retina from a 76 year old patient with AMD
demonstrating CRALBP.rg-opsin.τ→ rgb in (A), taurine labeling in (B),
glutamate labeling in (C) and cone opsin in (D). This image composite
shows RPE bricking as well as cone opsin bounded taurine and glutamate
rich deposits underneath the RPE. Cone opsin delocalization is also shown in
(A,D). Scale bar = 80 µM.
of presumptive healthy retina for the earliest manifestations
of pathology. While rod loss is normal in aging (Parapuram
et al., 2010), it is also accelerated in early AMD (Curcio, 2001)
and there is no evidence that the disease process itself ceases
at the boundary of the fovea or macula. Indeed, studies on
protein expression changes in macula and periphery found
that the majority of protein changes in AMD happened in
the periphery (Ethen et al., 2006) and contrast sensitivity in
the periphery is lower in AMD patients than in controls
(Faria et al., 2015). Additionally, mitochondria in the peripheral
RPE of AMD patients exhibits damage (Terluk et al., 2015) and
Frontiers in Cellular Neuroscience | www.frontiersin.org 7 April 2016 | Volume 10 | Article 103
Jones et al. Retinal Remodeling in Human AMD
FIGURE 7 | Graphs demonstrating glutathione concentration in the inner segments of cone photoreceptors over retinal eccentricity in four example
patients, normal, early-AMD, early wet-AMD, with neovascularization present, but prior to large scale bleeds in the retina and late wet-AMD with
prevalent evidence of resolved retinal bleeding. Normal glutathione concentration is very low, but becomes dramatically variable in central retina of wet-AMD.
Each plot represents data from a single individual (n = 1) of normal, early, dry-AMD, early wet-AMD and late we-AMD.
investigators have explored clinically observable changes in
the peripheral retinas of patients with AMD (Reznicek et al.,
2012).
For these reasons, we believe the peripheral retina from
AMD patients is a tremendous resource to understand disease
progression.
Visualization of Metabolism in AMD Retina
with CMP
CMP allows us to visualize the metabolic state of the retina
in health and disease, revealing pathologies that are undetected
by other methodologies. For instance, the presence of variable
concentrations of glutamate and taurine in RPE and cone
photoreceptors suggests the possibility of a late phase cell
death signature and the collapse of GS labeling in retinas of
AMD patients is notable for its potential contribution to the
metabolic alterations or chaos invoked, particularly inMüller cell
populations.
Using CMP to examine AMD pathogenesis reveals cell
metabolic state, and provides the ability to precisely define
individual cell classes affected by disease processes while
preserving the histologic and anatomic context. Thus, the
use of CMP for assessing the metabolome of AMD provides
important new biological information pertaining to metabolic
diversity across cell classes, while demonstrating tight regulation
of metabolic envelopes within cell classes (Marc et al., 1995;
Kalloniatis et al., 1996; Marc and Cameron, 2001; Marc and
Jones, 2002).
Retinal Remodeling in AMD
Early studies demonstrated photoreceptor loss in AMD (Curcio
et al., 1996), and photoreceptor loss associated with drusen
(Johnson et al., 2003). Additional studies have explored synaptic
alterations and altered gene expression in photoreceptors
(Johnson et al., 2005), and examined synaptic plasticity in
AMD at all eccentricities (Sullivan et al., 2007). This article
shows in AMD, that alterations of small molecule signatures
of the RPE, cone photoreceptors and Müller cells indicate
that early stress presages later photoreceptor loss and retinal
remodeling (Figures 3, 6, 8–10), particularly underneath drusen
(Figures 3, 9). This retinal remodeling is itself a likely cause of
blindness, even before complete photoreceptor loss occurs and
is a novel finding. Importantly, this remodeling occurs in the
presence of rods. Retinal remodeling in RP occurs primarily in
response to cone loss (Jones et al., 2003, 2005, 2006, 2011, 2012;
Marc and Jones, 2003; Marc et al., 2003, 2005, 2007, 2008; Jones
and Marc, 2005). Cones appear to stabilize the retina in RP while
this work demonstrates that early cone stress appears to induce
retinal neural network remodeling in the presence of cones, the
mirror image of what is observed in early retinal reprogramming
in RP.
Regardless of the precise triggering event(s) that provokes
the subsequent RPE-retina pathology, it is clear that the major
downstream consequences of these processes are the deposition
and sequestration of cellular and acellular debris in the remnant
sub-RPE space (drusen), photoreceptor cell degeneration and,
eventually, concomitant loss of vision. Over the past decade,
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FIGURE 8 | Two retinas from 75 year old patients with early dry-AMD in (A–C) with J.Q.DAPI→ rgb in (A), glutathione labeling in (B), glutamine
labeling in (C), and mid to late stage wet-AMD in (D–F) with γ.G.E→ rgb shown in (D), glutathione in (E) and glutamine in (F). Boxes (higher magnification
in G,H) show Müller glia that has dramatically elevated glutathione and glutamine signals in isolated or groups of glia. In the case of wet-AMD (D–F), the ONL is
dramatically thinner than in the early dry-AMD retina (A–C) and appears much more distinct because of this loss of photoreceptor cell nucleii. (G,H) Show increased
magnification views of the boxes in (B,C,E,F) for glutathione and glutamine channels respectively. Scale bar = 80 µM. Asterisks demonstrate drusen (*).
proteomic, molecular, genomic and mass spectroscopy-based
metabolomic assays have revealed tremendous insight into
pathologies and proposed mechanisms of AMD, but little about
the heterocellular diversity of the choroid-RPE-retina complex or
of the fates of neurons in the inner retina. The same was true in
RP and models of RP where the discovery of retinal remodeling
in over 30 separate models of RP was uniquely attributable to
studies that employed CMP as a means to interrogate complex
retinal tissues (Jones et al., 2003, 2005, 2006, 2011, 2012; Marc
and Jones, 2003; Marc et al., 2003, 2005, 2007, 2008; Jones and
Marc, 2005). Because inflammation plays a clear role in the
etiology of early AMD (Hageman et al., 2005), our perspective
was that CMP had the potential to identify early, pre-cell death
signals that are uniquely associated with disease progression
as CMP has been used to identify and track heterogeneous
cell stress responses in inflammatory lung disease, and identify
cell status in tissues prior to the time that clear differences
in gene or protein expression are observed (Jean et al., 2003)
and has the promise of providing insight into the dynamics of
protein transporters (Pow and Robinson, 1994; Sarthy et al.,
2005) and enzymatic activity (Pow and Crook, 1996; Marc et al.,
1998a,b).
RPE
Normal macular RPE are taller and narrower than those in
periphery (Streeten, 1969) allowing denser RPE cellspacking,
which appears necessary to maintain a low cone to RPE cell
ratio (Gao and Hollyfield, 1992). With increasing age some have
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FIGURE 9 | Peripheral retina from late stage dry AMD patient with drusen (*) demonstrating hypertrophy and metabolic alterations in Müller glial
cells. (A) Shows γ.G.E→ rgb and (B) shows τ.Q.E→ rgb. The inset rectangles demonstrate magnified regions shown in (C,D) revealing GABAergic labeling of
aberrant GABAergic processes (arrows) outside the normal lamination of the IPL in (C) and glycinergic labeling of a misplaced glycinergic amacrine cell in (D)
demonstrating clear plasticity and remodeling in inhibitory neuronal classes. Note, in the post-mortem state, GABA and glycine increase in the Müller cells. Scale bar
= 200 µM in (A,B). Scale bar = 40 µM in (C,D).
FIGURE 10 | Early stage dry AMD patient with very small drusen showing in τ.Q.J→ rgb labeling, (A) and τ.Q.J→ rgb overlay on top of transmission
electron microscopy (TEM) imagery in (B) with pure TEM imagery in (C). Black arrows demonstrate RPE cells with varying taurine, glutamine and glutathione
concentrations. Asterisks demonstrate cone photoreceptors with altered metabolic signatures showing decreases in taurine, and elevations in glutamine. Vertical
white arrows denote the presence of a small druse. Scale bar = 8 µM.
described the RPE as undergoing thinning and loss of cells, but
there is some disagreement as to the regional distributions of
these changes. Though other work has demonstrated rounding
and stacking of RPE, particularly at the borders of geographic
atrophy (Sarks et al., 1988; Vogt et al., 2011; Rudolf et al.,
2013; Bird et al., 2014). One study found that while RPE cells
were lost in large numbers in the periphery of the human
retina, macular regions failed to show any significant change
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(Gao and Hollyfield, 1992) while another study found that the
overall RPE to photoreceptor ratio dropped with age throughout
the retina (Dorey et al., 1989). Notably, cell-to-cell heterogeneity
is observed in nearly every measured parameter in aging human
RPE, and the degree of heterogeneity appears to increase with age
(Burke and Hjelmeland, 2005).
While there have been some reports that RPE cells can
divide (Al-Hussaini et al., 2008; Kokkinopoulos et al., 2011),
the evidence is sparse and it is clear that any cell division
that might be present does not occur at a fast enough rate to
compensate for disease processes that kill RPE cells in AMD. One
hypothesis for progression of dry forms of AMD is that as RPE
cells die, the photoreceptors internal to RPE become stressed and
subsequently die. Another hypothesis is that cell death within the
RPE might lead to redistribution of the remaining RPE cells and
that the natural conclusion would be that the numbers of RPE
cells remaining would at some point fail to have enough numbers
to sufficiently redistribute, leading to breaks in the RPE such as
those characteristic of more severe forms AMD. Extending that
line of thought, it is tempting to hypothesize that RPE cells die
faster in the central retina, causing the AMD phenotypes to be
reached sooner in the central retina than in the periphery, but no
data currently exists regarding the size, number, and position of
RPE cells in aging human retinas that can be conclusively tied to
retinal pathologies (Boulton and Dayhaw-Barker, 2001; Bonilha,
2008). That said, other studies have found no loss of RPE cells
with age, even with lipofuscin-attributable autofluorescence (Ach
et al., 2014). While CMP reveals more bricking in the RPE of
central retina than in the periphery (Figure 2) suggesting that
whatever mechanism is at work, central RPE cells have profiles
that suggest greater metabolic stress in the center of the retina
vs. the periphery and this correlates with pathological changes
observed in aging and AMD in the retinas of human patients
with AMD (Bonilha, 2008). Regardless of whether the RPE cells
persist in normal aging or undergo cell death pathways in disease
processes, aberrant signatures reveal altered metabolic status,
possibly indicating cell stress pathways that may lead to neural
retinal stress and subsequent pathologies.
The increases in glutathione in central retina of AMD subjects
examined perhaps is reflective of the idea that the central
retina is subject to higher levels of oxidative stress than in the
periphery (Provis et al., 2005). Glutathione concentrations are
also heterogeneous in the RPE of AMD patients, likely due to
the decoupling patterns of RPE cells. If RPE cells are becoming
uncoupled in disease, individual metabolic envelopes might be
allowed to find new metastable states, or the new metabolic
signatures may reflect RPE cells. Metabolite fluctuations imply
decoupling, either by gap junctional conductance modulation
or alternatively, downregulation of connexin expression profiles.
Notably, bricking of RPE cells has also been observed
in animal models of other retinal degenerative diseases
(Marc et al., 2008).
Increased RPE glutathione may be an important marker
of retinal stress (Marc et al., 2008). Specifically, the increase
observed in glutathione in RPE cells occurs in focal regions
immediately associated with both wet and dry lesions as well
as in focal lesions from other disorders reflected in the Müller
glia (Marc et al., 2008). With respect to the RPE, it should be
noted that the human fovea lacks the retinal vascular arcades
present elsewhere in the neural retina (Snodderly et al., 1992),
meaning that any condition that distances the photoreceptors
and neural retina from the RPE or the underlying choroid,
distances the neural retina from from its only blood supply
(Provis et al., 2005). Additionally, cultured RPE cells can
bidirectionally transport glutathione (Lu et al., 1995), exhibit
polarized transport mechanisms (Li et al., 2011) and possess a
Na+-dependent transport mechanism on the apical surface of
non-transformed human RPE cultures (Kannan et al., 2001), but
it remains unknown what role this plays in the retina in vivo
(Davidson et al., 1994; Lu et al., 1995; Kannan et al., 2001).
Though hypoxic insult has been linked to oxidative stress in a
variety of cell types, it is possible that the increase in glutathione
in these cells is a response to the increased oxidative burden
experienced during lesion-induced hypoxia (Sternberg et al.,
1993; Schulz et al., 2000).
Glutathione is important in preventing lipid oxidation
and can also detoxify reactive aldehydes, both of which are
critical oxidative defenses in the RPE and photoreceptors.
However, despite the prominence of oxidative damage in AMD
research and the importance of glutathione in cellular oxidative
homeostasis, very little is known about the role of glutathione
in the retina proper of AMD retinas (Winkler et al., 1999). A
number of studies have examined serum levels of glutathione
in AMD patients, (Brantley et al., 2012a,b), but resolving
glutathione to specific cells or cell classes has not been done
prior to this study. While cultured RPE cells are protected
from oxidative insults by exogenous glutathione administration
and by inducers of intracellular glutathione synthesis, it is not
known whether glutathione levels are changed in the RPE in
AMD (Sternberg et al., 1993; Winkler et al., 1999). This study
demonstrates that glutathione levels do change, but on a cell
to cell basis within the RPE with wide variance of metabolic
concentrations at earlier stages of AMD in RPE that suggest
cell stress and possible cell death, perhaps representing cells
attempting to normalize oxidative demands before collapsing late
in the disease process.
Analysis of far more samples and correlation with precise
diagnosis and ideally, genetic screening of genes strongly
associated with AMD, e.g., CFH (Boon et al., 2009), ARMS2
(Fritsche et al., 2008; Friedrich et al., 2011) and HTRA1 (Dewan
et al., 2006) as well as seven new loci associated with AMD
(Fritsche et al., 2013) would be required to definitively identify
whether tiling in the RPE is a normal finding of aging, or if
it is associated with AMD. It could be that the tiling in the
RPE indicates a cell stress mechanism that eventually results
in photoreceptor cell death, leading to AMD. It could also
be that the RPE stress itself may be subsequent to other
disease progression mechanisms such as the ‘‘oil spill model’’
(Curcio et al., 2011) where cholesterol-rich lipoproteins needed
by photoreceptors are taken up by the RPE via plasma, then
exported to Bruch’s membrane which, over time accumulates
and becomes cross-linked, effectively fixing them in place,
building up into drusen that itself becomes cytotoxic and
proinflammatory. It could be that we are seeing the metabolic
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results of cell stress brought on by these ‘‘oil-spill’’ deposits along
Bruch membrane.
Photoreceptors
The observation of large deposits, rich in taurine in the very distal
outer segments of cone photoreceptors and material underneath
the RPE (Figures 2, 6), likely represent photoreceptor material
not yet phagocytosed by the RPE. Theses structures are bound
by a cone opsin immunoreactive membrane containing very
high concentrations of taurine and other small molecules. At
the same time, rod photoreceptor opsins in these regions do not
appear delocalized and are not building up material underneath
the RPE. It is true that in some regions there is rod opsin
delocalization, but in those regions, cones appear intact and
largely healthy. Therefore, the observation of delocalized rod
opsin, we believe is an early signal and cone opsin delocalization
is a later signal based upon the correlations of observations with
other pathologies. It should also be noted that both rod and
cone opsin delocalization in other retinal diseases have been
documented for over a decade (Milam et al., 2002). Rhodopsin
delocalization has been observed in other models of retinal
degeneration, but rod photoreceptor debris does not build up in
the sub-retinal space of AMD patients as it does in RP disorders
that involve RPE processing (Jones et al., 2003, 2011, 2012; Marc
and Jones, 2003; Jones and Marc, 2005).
Fundamentally, the importance of this observation is that it
suggests RPE cells are becoming differentially unable to process
cone outer segments while rod outer segments seem to be
processed normally by RPE in these regions. Given that the opsin
processing pathways are identical, there must be other aspects
to the phagocytosis of rod vs. cone pathways that are being
compromised in these retinas. Are cone turnover and processing
pathways compromised while rod opsin pathways are intact? We
are unable to say for sure based upon these observations alone,
but it does raise the spectre of cell specific defects when RPE cells
become compromised in AMD.
While taurine is known to be especially critical for the
maintenance of normal cellular volume in excitable cells such as
neurons and myocytes, and is stored in very high concentration
there (Huxtable, 1992; Militante and Lombardini, 2004), these
observed concentrations are much higher than normal. Taurine
has been demonstrated to assist in cellular defenses to oxidative
stress in a variety of ways. Increases in cellular taurine and
glutathione are thought to help cells cope with increased
oxidative stress and are considered markers for oxidative damage
(Huxtable, 1992).
Photoreceptor taurine concentrations are among the highest
in the body, and the delivery and maintenance of taurine in
the retina appears to be prioritized over most other areas of the
body. Animals deprived of dietary taurine deplete other tissues
before retinal levels are allowed to drop, and the retina is the
first tissue to be re-supplied following restoration of dietary
availability. Furthermore, taurine deficiency causes rapid retinal
degeneration, the severity of which is proportional to the degree
of deficiency (Hayes et al., 1975; Schmidt et al., 1976). However,
it is not known precisely why photoreceptors are so uniquely
dependent on taurine. Some studies have found that taurine
supplementation protects photoreceptors from light damage and
other insults thought to be oxidative in nature, so the oxidative
protection roles of taurine may also be of great importance to
photoreceptors (Boldyrev et al., 1999; Keys and Zimmerman,
1999). Taurine is also known to participate in regulation of
RPE phagocytosis, a process critical for normal photoreceptor
function (Ogino et al., 1983). Perhaps what we are seeing is an
inability to process taurine in cone photoreceptors by the RPE,
or alternatively there may be another mechanism operating that
is simply preventing the cone photoreceptors from undergoing
phagocytosis by the RPE and taurine is building up in debris
underneath the RPE.
Glutamine Synthetase
Finally, our data conflict with previous reports on GS expression
being preserved in retinal disease (Strettoi et al., 2002; Roesch
et al., 2012) irrespective of whether the retinal degeneration
is brought on by retinal detachment (Lewis et al., 1994), RP
based mechanisms or AMD based mechanisms observed in this
study. We find effectively no GS in late stage AMD, raising
questions of impact on overall retinal metabolic fluxes and
homeostasis. Though GS is located in Müller cell populations
in normal tissues (Riepe and Norenburg, 1977), and assists the
glutamate/glutamine cycle through conversion of extracellularly
derived glutamate into glutamine (Riepe and Norenburg, 1977),
its absence implies that the retinal microenvironment around
Müller cells may no longer support cone function (Bringmann
et al., 2006). Indeed, some studies that have ablated Müller
glia have observed implications for photoreceptor survival (Shen
et al., 2012). Though that study selectively ablated Müller cells
completely, one might imagine a more selective impact on GS
might lead to similar results.
SUMMARY
This manuscript adds to the literature supporting alterations
of the RPE including RPE cell thinning underneath drusen
and alterations observed in aging/diseased human retinas and
ties these changes to the presence of other subsequent retinal
changes and most notably, retinal remodeling. These changes are
by definition, pathology and ultimately result in a progressive,
irreversible neural degeneration reflected by loss of retinal
neurons and glia in AMD. The pathologies begin with the earliest
indications of cell stress identified early through metabolic
instability in the RPE and in photoreceptors as well as Müller
glia. Additionally, cone opsin processing by the RPE appears
to be differentially impacted through an inability to process
cone opsin bound materials that build up underneath the RPE.
Neural retinal remodeling/plasticity in AMD is observed through
aberrant sprouting of amacrine cell processes and likely other
processes as well. This remodeling occurs early, particularly
underneath drusen and contrary to widely held belief, is a likely
contributor to visual loss even before photoreceptor cell loss
when both rod and cone photoreceptors are still present.
Before we can hope for long-term positive outcomes from
retinal vision rescues of all kinds, the vision science community
needs to address basic mechanisms for plasticity in that any
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rescue of vision whether via RPE replacement, photoreceptor
replacement via biological or bionic methods or gene therapy
will be compromised in some form by ongoing retinal plasticity.
The mechanisms at play in AMD will be particularly difficult
given the number of potential targets involved, but there may be
common pathways that lead to either cell survival or restraining
of plasticity by both neurons and glia.
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